| 崙棫堛栻昳怘昳塹惗尋媶強 |
National Institute of Health Sciences |
| 惗暔栻昳晹 |
Division of Biological Chemistry and Biologicals |
|
丂丂丂 |
亂rINN亃fresolimumab (List 63, 2010, Vol.24, No. 1, p56)
亂pINN亃fresolimumab (List 101, 2009, Vol.23, No. 2, p146)
亂夝愢乮榓栿乯亃
IgG4內, 峈僸僩庮釃憹怋場巕(TGFB, TGFbeta, TGF-beta丏TGF-beta-1 枖偼 TGFB1, 媦傃TGF-beta-2丆TGFB2
枖偼 G-TsF 暲傃偵 TGF-beta-3 枖偼 TGFB3傪娷傓), 僸僩儌僲僋儘乕僫儖峈懱; 柶塽挷惍嵻丏
H嵔 (兞4嵔丆1-447)丗[Homo sapiens VH (IGHV1-69*10 (89.70%) -(IGHD)-IGHJ3*01)
[8.8.13] (1-120) -IGHG4*01 (121-447)]丏
L嵔(內嵔丆1'-215')丗[Homo sapiens V-KAPPA (IGKV3-20*01 (93.80%) -IGKJ5*01) [7.3.9]
(1'-108') -IGKC*01 (109'-215')]丏
僕僗儖僼傿僪寢崌偺埵抲丗134-215', 226-226''丆229-229''
摐嵔晅壛埵抲丗297, 297''
亂暘巕幃亃C6392H9926N1698O2026S44
亂CAS斣崋亃948564-73-6
亂JAN亃枹廂嵹
|
|
| Copyright (C) 丂丂丂Division of Biological Chemistry and Biologicals丂丂丂All
rights reserved. |
|
|